TCRX
Tscan Therapeutics Inc
0.3335$
+0.8%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Tscan Therapeutics Inc (TCRX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/11/2026 | Current report (8-K) | TScan Therapeutics, Inc. (TCRX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 09/02/2026 | Current report (8-K) | TScan Therapeutics, Inc. (TCRX): Cost Associated with Exit or Disposal Activities; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/18/2026 | Current report (8-K) | TScan Therapeutics, Inc. (TCRX): Termination of a Material Definitive Agreement | View report ↗ |
| 08/12/2026 | Current report (8-K) | TScan Therapeutics, Inc. (TCRX): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.